Priya: An AI model would have to be projected to kill at least fifty people... before a new safety bill even considers kicking in.
Theo: This is Theo.
Priya: And I'm Priya.
Theo: And this is Money Daily for Wednesday, October 21st, 2026.
Priya: Today, we're tracking the money behind the future.
Theo: Coming up: an AI safety bill that might not be so safe after all.
Priya: Plus, two of Elon Musk’s companies are exploring a mega-merger.
Theo: And OpenAI is making a huge play in biotech.
Theo: Alright Priya, let's start with that AI safety bill.
Priya: This comes from AI company Anthropic. They've pitched a bill called the 'Responsible AI Development and Safety Act'.
Theo: Right, you mentioned the threshold at the top. The idea is, if a model could cause catastrophic harm, it gets a closer look.
Priya: And they define 'catastrophic harm' as something that could kill fifty or more people, or cause over fifty billion dollars in economic damage.
Theo: Okay, that sounds like a reasonable guardrail. We don't want Skynet. So what's the catch?
Priya: The catch is who gets to decide. The bill proposes a new federal agency, the AI Safety and Research Administration, or AISRA.
Theo: Also sounds good. An agency dedicated to AI safety.
Priya: But the fine print is where it gets you. The bill would actually forbid that agency from blocking a model without getting a federal judge to sign off first.
Theo: Wait—what? So the safety agency isn't the final word on safety?
Priya: Exactly. It shifts power from federal experts to the courts. It's an extra layer of red tape that a giant like Anthropic can handle way easier than a startup.
Theo: So it looks like a safety bill, but it's really just a moat for the big players, making it harder for the government to act fast.
Priya: It's a masterclass in regulatory capture before the regulation even exists.
Theo: The takeaway here is, when you see Big Tech proposing safety rules, always ask who they really benefit. It’s not always the public.
Priya: Always read the terms and conditions.
Theo: Next, a potential corporate family reunion: SpaceX and Tesla.
Priya: The boards of both companies have formed special committees to review a possible merger. This is according to reporting from TechCrunch.
Theo: Okay, so Elon Musk runs both companies. A merger seems... logical? Consolidate the empire?
Priya: From a synergy perspective, maybe. You have Tesla's battery and manufacturing expertise, and SpaceX's... rockets and satellites. But legally and financially, it's a minefield.
Theo: Right, Tesla is a publicly traded company. SpaceX is still private, though massive.
Priya: Valuing SpaceX is the first hurdle. It's privately held, so there's no public stock price. They'd have to agree on a number, and Tesla shareholders would have to believe it's fair.
Theo: And Musk says he's not on either committee, which are made up of 'independent directors'.
Priya: 'Independent.' The web of relationships on these boards is notoriously complex. But forming the committee is the right move, procedurally, to head off shareholder lawsuits claiming Musk is just lining his own pockets.
Theo: So why now? Is there a big reason to do this?
Priya: It could be about capital. A combined company might have an easier time raising the massive amounts of cash needed for Musk's Mars ambitions or Tesla's next generation of vehicles.
Theo: Or it could just be about simplifying his life. Running two giant, complex companies has to be... a lot.
Priya: I'm sure that's his primary concern. The logistics are staggering. Think about the debt, the different ownership structures...
Theo: For Tesla shareholders, this means get ready for a lot of debate about the company's future. A merger could send the stock on a wild ride.
Priya: This is just the first step. Expect months, if not years, of analysis and drama.
Theo: And now, from outer space to inner space. OpenAI is buying a biotech startup.
Priya: They've acquired Orchestra Bio. It's what's known as an 'acqui-hire'—they're mainly buying the team and their tech.
Theo: And they're folding them into a project called Rosalind. I like the name.
Priya: Named after Rosalind Franklin, the chemist whose work was crucial to understanding DNA. Rosalind is OpenAI's model for life sciences research.
Theo: So they're trying to do for biology what models like GPT-4 did for language—understand and generate complex information.
Priya: Precisely. The goal is to speed up drug discovery and protein design. Orchestra Bio brings expertise in a tool called the Rosalind Workbench.
Theo: A workbench. So it's a tool for researchers to use the big AI model, not just the model itself?
Priya: Exactly. It’s a user interface that lets scientists who aren't AI experts actually apply these powerful models to their work.
Theo: So the key isn't just the AI, it's making it usable for the scientists on the ground.
Priya: OpenAI clearly thinks so. The financial terms weren't disclosed, but it signals a serious push into the healthcare and biotech space.
Theo: This is huge. The potential for AI in medicine is one of the things I'm most optimistic about.
Priya: And one of the areas with the most potential for things to go spectacularly wrong if not handled with care. Remember our first story.
Theo: Fair point. But for now, the big picture is that the AI revolution is moving beyond chatbots and into the physical world—starting with life itself. The long-term impact on healthcare could be enormous.
Theo: Alright, let's do a quick recap.
Priya: Anthropic proposed an AI safety bill that critics say really just helps big AI companies, not the public.
Theo: The boards of Tesla and SpaceX are officially exploring a merger, which could create one of the most valuable and complex companies on Earth.
Priya: And OpenAI is doubling down on biotech, acquiring Orchestra Bio to boost its AI for life sciences research.
Theo: Before we go, Priya, a little fun fact for October 21st. On this day in 1879, Thomas Edison first tested his incandescent light bulb.
Priya: Ah, the original disruptive technology. I read his lab notebooks were a mess.
Theo: And now we're talking about AI models that could design better light bulbs... or shut down the entire grid. Progress!
Priya: And that's all the time we have for Money Daily.
Theo: We'll be back tomorrow with more. And Priya, try to find one optimistic angle on the terms and conditions before then.
This show is made with AI: the hosts’ voices are synthetic and the scripts are AI-assisted. Every story links to its original source.